AbbVie, Vertex Pharmaceuticals, Eli Lilly and Company, Thermo Fisher Scientific, and Colgate-Palmolive are the five Pharmaceutical stocks to watch today, according to MarketBeat’s stock screener tool.

Concord Asset Management LLC VA boosted its holdings in shares of Colgate-Palmolive (NYSE:CL – Free Report) by 46.1% during the fourth quarter, according to its most recent disclosure with the ...

Colgate-Palmolive’s (NYSE: CL) stock faced a downturn as the company’s future guidance failed to align with investor expectations, despite a strong fourth-quarter earnings beat. The personal care ...

Strong earnings, soaring organic sales, and record-breaking margins--Colgate is winning, but currency headwinds loom.

Colgate-Palmolive reported stable earnings for Q4 2024, beating EPS estimates but just missing revenue expectations.

Q4 2024 Management View CEO Noel Wallace highlighted net sales of $20 billion in 2024, achieving this milestone one year ...

The headline numbers for Colgate-Palmolive (CL) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall ...

Colgate-Palmolive maintained its leadership position in oral care, with a 41.4% global market share in toothpaste and a 32.2% ...

Colgate-Palmolive reported a slight decline in Q4 sales, dropping 0.12% to $4.94 billion, missing estimates. However, organic ...

Net sales decreased 0.1%; Organic sales* increased 4.3%, including a 0.5% negative impact from lower private label pet volume GAAP EPS increased 3% to $0.90; Base Business EPS* increased 5% to $0.91 ...

What is the outlook of the Colgate Palmolive stock price ahead of earnings? We explain whether it may drop soon ...

Prabhudas Lilladher recommended hold rating on Colgate Palmolive with a target price of Rs 2801 in its research report dated January 28, 2025.